3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
2
Status
Recruiting
3
Completed
2
Sponsor Class
OTHER
2
OTHER_GOV
1
Study Type
Interventional
2
Observational
1
Sponsor
Cancer Type
Other hematologic neoplasm
3
Lymphoid
3
Plasma cell
2
Conditions
Breast Neoplasms
5
Neoplasms
4
Neoplasm Metastasis
4
Multiple Myeloma
3
Lymphoma
3
Leukemia
3
Hematologic Neoplasms
3
Triple Negative Breast Neoplasms
2
Prostatic Neoplasms
2
Glioblastoma
2
Urinary Bladder Neoplasms
1
Rectal Neoplasms
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Ovarian Neoplasms
1
Malignant Female Reproductive System Neoplasm
1
Localized Head and Neck Carcinoma
1
Leukemia, Myeloid, Acute
1
Hematopoietic and Lymphoid System Neoplasm
1
Gastrointestinal Neoplasms
1
Fatigue
1
Fallopian Tube Neoplasms
1
Endometrial Neoplasms
1
Depression
1
Colonic Neoplasms
1
Chemotherapy Effect
1
Caregiver Burden
1
Carcinoma, Non-Small-Cell Lung
1
Anxiety Disorders
1
Agnosia
1
Advanced Malignant Solid Neoplasm
1
Interventions
venetoclax
22
Cyclophosphamide
14
Cytarabine
12
Azacitidine
8
fludarabine
7
Daunorubicin
5
ruxolitinib
4
revumenib
4
Trimethoprim, Sulfamethoxazole Drug Combination
4
Dexamethasone
4
quizartinib
3
pirtobrutinib
3
gamma-Globulins
3
fludarabine phosphate
3
blinatumomab
3
Tacrolimus
3
Rituximab
3
Palliative Care
3
Granulocyte Colony-Stimulating Factor
3
Decitabine
3
Ciprofloxacin
3
Blood Specimen Collection
3
zanubrutinib
2
pembrolizumab
2
ibrutinib
2
aldesleukin
2
acalabrutinib
2
Watchful Waiting
2
Mycophenolic Acid
2
Melphalan
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
3 trials
Recent
Start date
Enrollment
Recruiting
×
Leukemia
×
Palliative Care
×
Clear all
NCT05646576
2026-04-21
PEACE
Massachusetts General Hospital
Phase NA
Recruiting
90 enrolled
NCT07258043
2025-12-02
EPOCH
Hospital General de Mexico
Recruiting
45 enrolled
NCT05190653
2024-07-31
PALS_CT
Alberta Health Services, Calgary
Phase NA
Recruiting
152 enrolled